What to know about glaucoma as cases expected to spike to 1.6 million

Researchers have predicted that cases of glaucoma, a common eye condition that can lead to blindness if not treated, are ...

What is glaucoma and what are the main symptoms to look out for?

Cases of this eye condition are expected to increase to 1.6 million in the UK by 2060.

In the blink of an eye - Sheffield clinic supports January’s Glaucoma Awareness Month

Glaucoma is one of the leading causes of irreversible blindness worldwide for people over the age of 60 but early detection ...
Cornwall Live on MSN

Symptoms of glaucoma as cases to soar 60 per cent

Left untreated, glaucoma can lead to blindness ...
GB News on MSN

Millions face 'irreversible sight loss' as glaucoma cases set to jump 60% in coming decades

The number of people living with glaucoma in the UK is set to surge dramatically over the coming decades, with new research ...

Fetty Wap Is Home With His Family, Freedom, and Future In Focus

The platinum-selling artist's purpose and perspective are clearer than ever ...

Vance Thompson Vision Highlights Advanced Glaucoma Treatment Options in Billings, Montana

Billings, MT - January 26, 2026 - PRESSADVANTAGE - Patients seeking expert care for glaucoma in the region are turning ...
MassDevice

Shifamed’s Myra Vision treats first glaucoma patient in Calibreye clinical trial

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

Advanced Glaucoma Treatment Options Now Accessible in Cedar Rapids through Vance Thompson Vision

CEDAR RAPIDS, IA - January 27, 2026 - PRESSADVANTAGE - As cases of glaucoma continue to rise across the United States, ...
Ophthalmology Times

Myra Vision treats first patient in ADAPT trial of Calibreye TGT Surgical System

Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...

First Patient Treated in Myra Vision's U.S. ADAPT Clinical Study for Glaucoma

The MarketWatch News Department was not involved in the creation of this content.-- Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas -- The IDE study wi ...